Phase I study of the Hedgehog pathway inhibitor IPI-926 in adult patients with solid tumors. [electronic resource]
Producer: 20131216Description: 2766-74 p. digitalISSN:- 1557-3265
- Adult
- Aged
- Aged, 80 and over
- Alanine Transaminase -- metabolism
- Alopecia -- chemically induced
- Area Under Curve
- Aspartate Aminotransferases -- metabolism
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Fatigue -- chemically induced
- Female
- Follow-Up Studies
- Hedgehog Proteins -- metabolism
- Humans
- Male
- Metabolic Clearance Rate
- Middle Aged
- Nausea -- chemically induced
- Neoplasms -- drug therapy
- Signal Transduction -- drug effects
- Spasm -- chemically induced
- Treatment Outcome
- Veratrum Alkaloids -- adverse effects
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.